<?xml version="1.0" encoding="UTF-8"?>
<p>Th17 cell responses are also involved in the immune pathogenesis of COVID-19, mainly with the secretion of various cytokines, such as IL-17, granulocyte-macrophage colony-stimulating factor, IL-21, and IL-22[
 <xref rid="B42" ref-type="bibr">42</xref>]. IL-1b and TNFα, as promoters of human Th17 cell differentiation, are also involved in stimulating vascular permeability and leakage. Nevertheless, it was shown that patients with a severe form of COVID-19 had increased levels of CCR+ Th17 cells[
 <xref rid="B39" ref-type="bibr">39</xref>]. This may suggest that Th17 cells and their cytokines are also involved in the cytokine storm. Besides, elevated Th17 and Th1 cell responses were also described in MERS-CoV and SARS-CoV patients[
 <xref rid="B43" ref-type="bibr">43</xref>,
 <xref rid="B44" ref-type="bibr">44</xref>]. These results support the hypothesis that enhanced IL-17-related pathways, including higher IL-17 but lower IFNγ and IFNα, are associated with worse outcomes for the patients[
 <xref rid="B39" ref-type="bibr">39</xref>].
</p>
